Sigyn Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	0	0	0	0	0.14	0.03	1.28	1.8	0.03	0.04
Revenue Growth (YoY)	-	-	-	-	405.58%	-97.79%	-28.84%	6078.61%	-32.32%	-
Cost of Revenue	0.01	0.01	0	0.01	0.04	0.01	0.51	1.03	0.01	0.03
Gross Profit	-0.01	-0.01	-0	-0.01	0.11	0.02	0.77	0.77	0.02	0.02
Selling, General & Admin	1.65	1.49	1.27	0.89	0.63	1.02	3.21	1.48	2.27	0.41
Research & Development	0.8	0.66	0.73	0.03	0	0	0	0	0	0
Other Operating Expenses	0	0	-0.54	0	0	0.11	3.21	0	0	0
Operating Expenses	2.45	2.15	2.01	0.92	0.63	1.02	3.21	1.48	2.27	0.41
Operating Income	-2.46	-2.15	-2.01	-0.92	-0.52	-1	-2.43	-0.71	-2.25	-0.39
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	2.04	0.65	0.4	0.34	0.06	0.35	0.79	0.05	0.44	0
Other Expense / Income	-0.35	0.14	0.6	0	2.74	1.26	1.03	0.07	-	-
Pretax Income	-4.15	-2.93	-3	-1.26	-3.31	-2.3	-4.25	-0.83	-2.69	-0.39
Income Tax	0	0.78	0.4	0.34	-0.18	0	0	0	0	0
Net Income	-4.15	-3.71	-3.4	-1.6	-3.13	-2.62	-4.25	-0.83	-2.69	-0.39
Shares Outstanding (Basic)	1	37	36	7	1	0	0	0	0	0
Shares Outstanding (Diluted)	1	37	36	7	1	0	0	0	0	0
Shares Change	-97.06%	2.75%	395.11%	1256.72%	24.90%	38.17%	4239.14%	-96.84%	22.79%	-
EPS (Basic)	-3.77	-0.10	-0.09	-0.22	-5.78	-6.04	-13.54	-114.92	-11.77	-2.08
EPS (Diluted)	-3.77	-0.10	-0.09	-0.22	-5.78	-6.04	-13.54	-114.92	-11.77	-2.08
Free Cash Flow	-1.38	-1.83	-1.8	-0.84	-0.14	-0.29	-0.48	-0.25	-0.1	-0.05
Free Cash Flow Per Share	-1.26	-0.05	-0.05	-0.11	-0.27	-0.68	-1.53	-34.44	-0.42	-0.26
Gross Margin	-	-	-	-	75.12%	65.74%	60.10%	42.72%	66.00%	41.49%
Operating Margin	-	-	-	-	-361.39%	-3544.18%	-189.56%	-39.36%	-7714.35%	-898.05%
Profit Margin	-	-	-	-	-2183.82%	-9243.24%	-331.05%	-46.08%	-9224.88%	-898.05%
Free Cash Flow Margin	-	-	-	-	-100.25%	-1039.10%	-37.31%	-13.81%	-329.62%	-111.01%
EBITDA	-2.45	-2.27	-2.05	-0.91	-0.44	-0.76	-2.2	-0.62	-2.25	-0.39
EBITDA Margin	-	-	-	-	-308.84%	-2671.50%	-171.20%	-34.56%	-7710.39%	-898.05%
Depreciation & Amortization	0.01	0.01	0.02	0.01	0.08	0.25	0.24	0.09	0	0
EBIT	-2.46	-2.28	-2.07	-0.92	-0.52	-1	-2.43	-0.71	-2.25	-
EBIT Margin	-	-	-	-	-361.39%	-3544.18%	-189.56%	-39.36%	-7714.35%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.